The End of Slow Science: Inside Pharma’s AI-Accelerated Future
Join us on January 14th for JPM Healthcare Satellite Happy Hour and Panel Discussions on AI and Biopharma Innovation.
Speakers for our two panel sessions:
Vivek Adarsh, Co-Founder & CEO, Mithrl
Mark Budde, Co-Founder & CEO, Plasmidsaurus
Rayyan Sheikh, Discovery & Innovation Research Leader, Roche
Morten Sogaard, SVP Innovation, Astellas
Uli Stilz, Global BioPharma leader and Board Member
Hinco Gierman, CSO, Elephas
Steven Henck, VP and NGS Fellow, Danaher (IDT)
Gordon Sanghera, Founder & CEO, Oxford Nanopore Technologies
Christopher Szeto, Snr. Director of Discovery Bioinformatics, Exelixis
Moderator: John Cumbers, Founder & CEO, SynBioBeta
Who: A must-attend for scientists, biotech innovators, pharma leaders, and investors who want an edge in shaping, and capitalizing on the next wave of therapeutic discovery.
Leaders spanning pharma, biotech, and AI will share perspectives on what will propel and constrain the next therapeutic discovery era. Expect a dynamic debate with experts and the chance to connect, all to a backdrop of gourmet food and craft beverages.
Agenda:
5-5:30 opening reception
5:30-6:00 first panel
6:00-6:30 networking break
6:30-7 second panel
7-8 networking happy hour
You are welcome to share this with your network. This event is complimentary (requests will be reviewed for domain relevance to ensure an optimal networking experience for all). To ensure your approval, please provide your work email. All attendees must be registered in advance for event entrance.
This event is hosted by Mithrl. Co-sponsors making this event possible are:
Integrated DNA Technologies (IDT)
Oxford Nanopore Technologies (ONT)
We hope you will join us!
About Mithrl
Mithrl is the Life Sciences AI Co-Scientist that serves to complement and unify pharma discovery teams. Within one platform, bench scientists and computational biologists accelerate analyses and contextualize results within comprehensive bio-insights. With Mithrl, scientists work to discover new biomarkers, identify new therapeutic targets, understand mechanisms of action, and ultimately create new IP opportunities. Mithrl adapts and responds to user-prompted or Mithrl-suggested questions to take discovery further, faster, all in a single, reproducible environment. Follow Mithrl on social: linkedin.com/company/mithrl-ai and x.com/mithrl_ai
About Integrated DNA Technologies
Building from a strong foundation of innovation, expertise, and reliability, Integrated DNA Technologies (IDT) has evolved from an oligo manufacturer to a leading genomics provider. We work shoulder-to-shoulder with scientific and global health partners to enable genomics breakthroughs at scale. Our vision of enabling researchers to rapidly move from the lab to life-changing advances reflects our ongoing commitment to a healthier, brighter future for all.
For more information about IDT, visit www.idtdna.com and follow the company on LinkedIn, X, Facebook, YouTube, and Instagram.
Disclaimer: RUO — For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.
About Oxford Nanopore Technologies
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used in more than 125 countries to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments.
For more, visit: https://nanoporetech.com/
About Plasmidsaurus
Plasmidsaurus is on a mission to accelerate science with the best sequencing. The company's sequencing services, spanning whole plasmids, RNA-seq, amplicons, whole genomes, AAV, and microbiomes, are used daily by thousands of innovators, including Nobel Prize winners, dynamic biotech startups, pharmaceutical companies, research labs, and DIY biohackers. Plasmidsaurus's global network of labs operates day and night to enable world-changing discoveries. For more, visit: plasmidsaurus.com
About DNAnexus
DNAnexus is a cloud-based data platform that enables organizations to securely manage, analyze, and collaborate on genomic and biomedical data at scale. It provides tools and infrastructure for running bioinformatics workflows, integrating multi-omics and clinical data, and meeting strict regulatory and compliance requirements, helping researchers, biotechs, and pharma teams turn complex biological data into actionable insights.
About Goodwin
Goodwin is a global law firm headquartered in the United States with more than 2,000 lawyers across offices in North America, Europe, and Asia, offering complex transactional, litigation, regulatory, and advisory legal services. The firm focuses on key industries including private equity, technology, life sciences, real estate, financial services, and investment funds, helping companies, investors, and institutions navigate legal challenges, close major deals, manage risk, and achieve strategic goals.
Please note that photographs and footage will be taken throughout the event. These will be used by all co-sponsors for marketing and publicity in our publications, on our website and in social media or in any third-party publication. Please contact the event host if you have any concerns or if you wish to be exempted from this activity.